Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing Publicly Funded Fetal Exome Sequencing: A Statewide Multidisciplinary Model for Equitable Integration of Genomics Into Perinatal Care.

Prenatal diagnosis·2025
Same author

A Diagnosis of Maturity-onset Diabetes of the Young Type 5 Provides Clarity and Broadens Reproductive Options.

JCEM case reports·2025
Same author

Case Series of Resuscitative Hysterotomy in Pregnant Trauma Patients Performed in the Emergency Department of a Level One Major Trauma Service.

Emergency medicine Australasia : EMA·2025
Same author

Maternal Metabolic Health and Mother and Baby Health Outcomes (MAMBO): Protocol of a Prospective Observational Study.

JMIR research protocols·2025
Same author

In-utero transfer, survival-focused care and survival to 28-days at 22-24 weeks' gestation pre- and post- implementation of an extreme prematurity management guideline in Victoria, Australia.

BMJ paediatrics open·2024
Same author

Pharmaceuticals in pregnancy: a multifaceted challenge in Australia.

The Medical journal of Australia·2024
Same journal

Anti-GAD antibody-associated epilepsy in pregnancy.

Obstetric medicine·2026
Same journal

Eplerenone in pregnancy.

Obstetric medicine·2026
Same journal

Postpartum therapeutic anticoagulation and uterine wall haematoma: A case report.

Obstetric medicine·2026
Same journal

The prevalence of the common LCHAD c.1528G>C p.(Glu510Gln) pathogenic variant in women diagnosed with acute fatty liver of pregnancy.

Obstetric medicine·2026
Same journal

Renal tubular acidosis (RTA) complicated pregnancies: A tertiary centre experience.

Obstetric medicine·2026
Same journal

A woman with homozygous familial hypercholesterolaemia requiring lipoprotein apheresis and coronary artery bypass graft in pregnancy.

Obstetric medicine·2026
See all related articles

Related Experiment Video

Updated: Mar 15, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

10.2K

First trimester screening for pre-eclampsia.

Stefan C Kane1

  • 1Department of Obstetrics and Gynaecology, The University of Melbourne, Melbourne, Australia; Pregnancy Research Centre, Department of Maternal-Fetal Medicine, The Royal Women's Hospital, Parkville, Victoria, Australia.

Obstetric Medicine
|September 16, 2016
PubMed
Summary
This summary is machine-generated.

New pregnancy screening tests show high detection for early pre-eclampsia but limited prediction for later onset. Further research is needed before widespread clinical use.

Keywords:
Pre-eclampsiafirst trimester of pregnancypredictive value of testsscreening

More Related Videos

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
05:30

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

999
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.5K

Related Experiment Videos

Last Updated: Mar 15, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
09:04

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

10.2K
Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
05:30

Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis

Published on: November 8, 2024

999
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.5K

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Clinical Screening

Background:

  • First-trimester screening tests for pre-eclampsia are now commercially available.
  • These tests have generated debate regarding their clinical utility and adherence to screening principles.

Purpose of the Study:

  • To evaluate the clinical utility of first-trimester pre-eclampsia screening tests.
  • To assess the performance of these tests in predicting early and late-onset pre-eclampsia.

Main Methods:

  • Review of existing studies on the performance of first-trimester pre-eclampsia screening tests.
  • Analysis of detection rates and false positive rates for early and late-onset pre-eclampsia.

Main Results:

  • Tests achieve over 90% detection for early pre-eclampsia (delivery <34 weeks) with a 10% false positive rate.
  • Prediction capacity for later onset pre-eclampsia, which represents the majority of cases, is significantly more limited.
  • Validation studies show considerable performance variations across different populations.

Conclusions:

  • Further test development is recommended before clinical implementation.
  • Prospective research is required to confirm aspirin's efficacy in high-risk screened groups and assess potential harms.
  • Current tests may not fully meet established screening principles for all forms of pre-eclampsia.